Current status of the field of obesity

Richard L Atkinson1

  • 1Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA; Obetech Obesity Research Center, Richmond, VA, USA.

Insights

Obesity medicine needs recognition, as current treatments often fail. Research into basic mechanisms and new drug development, informed by bariatric surgery, is crucial for effective obesity treatment.

Area of Science:

  • Obesity Medicine
  • Metabolic Research

Background:

  • Obesity is a complex medical condition requiring specialized treatment.
  • Current interventions like diet and exercise show limited long-term success.
  • The scarcity of effective pharmacotherapies highlights a significant treatment gap.

Purpose of the Study:

  • To advocate for the recognition of obesity as a distinct medical specialty.
  • To emphasize the need for enhanced research into obesity's fundamental mechanisms and diverse causes.
  • To explore the potential of bariatric surgery as a model for developing novel pharmacological treatments.

Main Methods:

  • Review of current obesity treatment modalities and their efficacy.
  • Analysis of the limitations in existing drug development for obesity.
  • Examination of bariatric surgery outcomes and their mechanistic insights.

Main Results:

  • Conventional obesity treatments (diet, exercise, lifestyle) exhibit high failure rates.
  • Existing obesity medications are limited in number and effectiveness.
  • Bariatric surgery demonstrates significant efficacy, offering valuable insights.

Conclusions:

  • Obesity medicine requires greater recognition and research focus.
  • Understanding obesity's basic science and etiologies is paramount.
  • Investigating bariatric surgery mechanisms can drive the development of superior drugs and treatments for obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
2.8K
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.6K